1. Introduction {#sec1}
===============

A cluster randomized controlled trial (RCT) is performed as an intervention in a group of subjects (collectively labeled as a 'cluster'), rather than for an individual. This design is used in emergency medicine when researchers would like to conduct clinical trials focusing on "cluster" such as fire department and emergency medical services (EMS) station \[[@bib1], [@bib2], [@bib3], [@bib4], [@bib5], [@bib6]\]. Sample size estimation in cluster RCTs requires the expected effect size of the test intervention, the intra-cluster correlation coefficient (ICC), the cluster size (i.e., the number of treated patients per EMS station), and the ratio of patient allocation between two groups, in addition to the type I error rate and the statistical power of testing \[[@bib7], [@bib8], [@bib9]\]. However, we often encounter the situation that the actual values of the cluster size and the ratio of allocated patients between two groups eventually differ from those used for sample size estimation because of the nature of patient enrollment \[[@bib6]\]. Furthermore, in cluster RCTs for EMS system, the difficulty lies in estimating the effect size of the test intervention and ICC used for sample size estimation, because few estimates of the effect size and ICC from existing research have been published, leaving investigators with little data on which to base their expectations in some cases \[[@bib10]\]. To improve efficient management on cluster RCTs, we need to understand the effect of the uncertainty of these design parameters on the type I error rate and power.

Recently, we started an open-label cluster RCT that enrolled 3000 to 5000 patients with out-of-hospital cardiac arrest (OHCA) and included 120 EMS stations from February 1, 2017 in Japan (UMIN000021431) to examine the clinical benefit of real-time feedback, debriefing, and retraining system of cardiopulmonary resuscitation (CPR) for OHCAs \[[@bib11]\]. The intervention group (high performance CPR group) in this trial refers to CPR that makes use of a real-time feedback device, which quantifies and monitors the quality of CPR (real-time feedback), combined with post-event debriefing and physical retraining. The control group (standard CPR group) is the standard CPR without real-time feedback, debriefing, and retraining using the use of a real-time feedback device. The 120 EMS stations were randomly allocated to high performance CPR group or standard CPR group on a 1:1 ratio. Therefore, the EMS personnel belonging to the same EMS station treat cardiac arrest patients using the allocated procedure. The primary endpoint was the proportion of patients who survive with 1-month favorable neurological survival, defined as cerebral performance category score 1 or 2, for one month after the event.

Before beginning the trial, under the conditions that we might encounter, we comprehensively examined the effect of inconsistencies in the actual ICC, cluster size, and ratio of patient allocation with those expected for sample size estimation on the type I error rate and power using simulation studies. With respect to the uncertainty of the effect size of the test intervention, we investigated the contribution of incorporating sample size re-estimation based on the observed difference in the 1-month favorable neurological survival between the two groups at an interim analysis of the trial for the power increase.

In this study, we share and discuss the remarkable effects of sample size estimation and re-estimations based on our cluster RCT for EMS system, with and without sample size re-estimation. In the following section, we briefly summarize the sample size estimation for cluster RCT, the definition of ICC, and the sample size re-estimation we used in our trial, respectively. Subsequently, we conducted comprehensive simulation study and discussed our findings.

2. Materials and methods {#sec2}
========================

2.1. Sample size calculation for a cluster RCT {#sec2.1}
----------------------------------------------

In the standard cluster RCT, the sample size is often calculated by,$$N = Jm = \frac{\left( {Z_{\alpha/2} + Z_{\beta}} \right)^{2}\left\lbrack {p_{t}\left\lbrack {1 - p_{t}} \right\rbrack + p_{c}\left\lbrack {1 - p_{c}} \right\rbrack} \right\rbrack\left\lbrack {1 + \left\lbrack {m - 1} \right\rbrack\rho} \right\rbrack}{\left( {p_{t} - p_{C}} \right)^{2}}$$where *p*~t~ and *p*~c~ are the expected proportion of 1-month favorable neurological survival in high performance CPR group and standard CPR group, respectively, *J* is the number of EMS stations, *m* is the cluster size for each station, and $\rho$ is the ICC \[[@bib9]\]. $\text{Z}_{\alpha\text{/}2}$ and $\text{Z}_{\text{β}}$ are the upper ($\alpha/2$)th and $\text{β}$th percentiles of the standard normal distribution, respectively.

In our trial, the *p*~t~ was set to 0.061914 based on data from Osaka prefecture of past 5 years and *p*~c~ was set to 0.038490 using odds ratio = 1.65, which was expected by previous research of real-time feedback or debriefing \[[@bib11]\]. To calculate the sample size required to achieve an 80% power ($\text{β}$= 20%) at 5% level of significance ($\alpha$= 5%) under this assumption, we further needed to specify the values of J and $\rho$, respectively. The specification of ICC $\left( \text{ρ} \right)$ is described in the following section.

2.2. Intra-cluster correlation coefficient {#sec2.2}
------------------------------------------

In this section, we introduce the ICC definition used in our trial. We supposed that the clustered, binary outcome variable (e.g., 1-month survival) is denoted by *Y*~ij~ (= 0 or 1) for the *j*th patient (*j* = 1, 2, ..., *m*~i~) in the *i*th cluster (i = 1, 2, ..., *J*), where m~i~ represents the cluster size. The intervention indicator is denoted by a dichotomous variable, *X*~ij~ (= 0 or 1) whose value depends only on the cluster; therefore, *X*~ij~ = *X*~i~.

The mixed effect and marginal probability models based on the generalized estimating equation (GEE) developed by Liang and Zeger \[[@bib12]\] take into account the correlation of patient survival outcome in the inferential processes. We considered the mixed effect model:$$\text{logit}\left( p_{ij} \right) = \alpha_{1} + \beta_{1}X_{i} + U_{i}$$where *p*~ij~ = *E*(*Y*~ij~\|*X*~*i*~*,U*~*i*~), $\alpha_{1}$ is a constant representing the baseline log-odds, and $\text{β}_{1}$ is population-average log-odds. The random variable, *U*~i~ is a random effect and is distributed with a mean of 0 and unknown variance $\sigma^{2}$, *U*~i~ ∼ Normal (0, $\sigma^{2}$). In the mixed effect model, the ICC ($\rho_{\text{lo}}$) is defined as $\sigma^{2}$/($\sigma^{2}$+$\text{π}^{2}/3$).

In our trial, the ICC estimate was $\rho_{\text{lo}}$  = 0.003, which corresponded to the value of $\sigma^{2}$  = 0.01. $\sigma^{2}$ was based on assuming random effect of about ±0.3 relative to β~1~. Thus, the required cluster size (or total sample size) when $\rho_{\text{lo}}$ = 0.003 was 25 (or approximately 3000) when the number of EMS stations were (*J* = ) 120.

In addition, we also considered the marginal probability model based on the GEE:$$\text{logit}\left( p_{ij} \right) = \alpha_{2} + \beta_{2}X_{i}$$

The parameter of 'exchangeable' compound symmetry correlation structure could be used as the ICC. Furthermore, it should be noted that in the case where the probability of success in a binary endpoint is low, the ICC tends to be low \[[@bib13]\]. Eldridge et al. \[[@bib8]\] have provided several definitions of ICC in cluster RCTs.

2.3. Sample size re-estimation {#sec2.3}
------------------------------

As we described earlier, the difficulty lies in the determining the expected difference in the 1-month favorable neurological survival between two groups in the sample size estimation. Although we assumed an expected odds ratio of 1.65, a lower odds ratio (e.g., 1.60 corresponding to proportion of 1-month favorable neurological survival of 3.8% and 5.95% in standard CPR and high performance CPR groups, respectively) would also be clinically significant. Therefore, we planned to conduct an interim analysis to re-estimate the required sample size during the trial. Among the several useful methods for sample size re-estimation, we used the approach proposed by Mehta and Pocock \[[@bib14]\] because it does not need to adjust the overall type I error rate of the trials, although careful inspection of the operating characteristics of the Mehta and Pocock (MP) method is required \[[@bib15],[@bib16]\]. Although we do not explain the MP method in more detail in this paper, the sample size increases when interim analysis results fall within a 'promising zone' (e.g., 50--80% of conditional power), where it is deemed worthwhile to increase the conditional power to detect the difference in the primary endpoint between the two groups by adding more patients.

2.4. Simulation studies {#sec2.4}
-----------------------

### 2.4.1. Simulation settings {#sec2.4.1}

The above-mentioned sample size estimation of 3000 patients (i.e., 25 of cluster size for each EMS station) assuming that p~t~ = 0.061914, p~c~ = 0.038490, $\rho_{\text{lo}}$  = 0.003, $\alpha$ = 0.05, and $\text{β}$  = 0.20 supposes an equal cluster size between the EMS stations, equal patient allocation between the groups, and a common expected ICC between the groups. These design parameters possibly differ from those observed in the actual trial; therefore, we investigated the type I error rate and statistical power of testing using the mixed effect model and GEE method under the following possible settings that we might encounter with respect to the cluster size, the ratio of patient allocation, and the ICC, with and without incorporating the sample size re-estimation through the simulation studies.

In the simulation studies, the 1-month survival probability was generated based on the mixed effect model such that p~t~ = exp(-3.231 + 0.497 + u~i~)/{1 + exp(-3.231 + 0.497 + u~i~)} (or p~c~ = exp(-3.231 + u~i~)/{1 + exp(-3.231 + u~i~)}), where u~i~ ∼ Normal(0, $\sigma^{2}$). The value of $\sigma^{2}$ was set to 0.01 ($\rho_{\text{lo}}$  = 0.003) or 0.11 ($\rho_{\text{lo}}$  = 0.032 as conservative setting) for the two groups. Five possible situations for cluster size were considered ([Table 1](#tbl1){ref-type="table"}). Situation 1 is ideal wherein the cluster size of all the EMS stations are the same; however, it is apparently impractical. In situations 2--5, the cluster size is varied depending on the EMS stations. Additionally, under situation 1, the power was also evaluated when the ratios of sample sizes for the high performance CPR group and standard CPR group were (1200:1800), (1000:2000), (1750:1275), (1800:1200), (2000:1000), and (1275:1750), respectively.Table 1Five cluster-size situations for each group.Table 1Cluster sizeNumber of EMS stationsNumber of patientsCluster sizeNumber of EMS stationsNumber of patientsCluster sizeNumber of EMS stationsNumber of patientsSituation 1Situation 2Situation 350056305210100010660104401500157105158120200020714020102002560150025820025123003000307210301030035003572453582804000406240404160450045627045290Situation 4Situation 551050500108801000156901512180204802010200254100251435030412030144203562103510350408320400045104504500[^2]

Using the above-mentioned probabilities and situations, the number of 1-month survivors in each group was generated based on the Binominal distribution (e.g., Binomial (1500, p~t~) and Binominal (1500, p~c~)) and subsequently, the mixed effect model and the GEE method introduced in the previous section were applied to estimate the odds ratio and its p-value. We performed 10,000 repetitions (i.e., 10,000 simulated trials) for each setting and reported the proportion of simulated trials in which the p-value was less than or equal to 0.05 as the statistical power of testing (or the type I error rate under the null hypothesis) and average of estimated odds ratio. In the case of incorporating sample size re-estimation, we also calculated the proportion of observing the 'promising zone' result among 10,000 simulated trials, as well as the average of the final sample size after sample size re-estimation. We used SAS version 9.4 software (SAS Institute Inc., Cary, NC, USA) to implement the simulation studies.

3. Results {#sec3}
==========

3.1. Mixed effect model and GEE {#sec3.1}
-------------------------------

We found that the parameter estimation of the random effect in the mixed effect model did not converge because of the extremely low rates of patient survival in each cluster. The successful parameter estimation of the mixed effect model was less than 50% of 10,000 simulated trials, while it was 100% for the GEE method; therefore, we present the results using the GEE in the following section. We set the main analysis as GEE, and the secondary analysis as mixed effect model.

3.2. Power {#sec3.2}
----------

[Table 2](#tbl2){ref-type="table"} shows the results of simulation studies with situations of varying ICC and cluster sizes. In the case where the value of $\rho_{\text{lo}}$ was identical to the expected value of 0.003 for both groups, and the cluster size was commonly 25 among the 120 EMS stations (i.e., Situation 1), the simulated power of 83% was almost same as the pre-specified target value of 80%. The average odds ratio of 1.68 was also close to the expected value of 1.65. The simulated power decreased by 3--4% when the ICC of the high performance and/or standard CPR groups increased to 0.032; however, those were between 76 and 85% in all the situations of cluster size we assumed in the simulation studies.Table 2Results of simulation studies with situations of varying ICC and cluster sizes.Table 2ICC of standard CPR groupICC of high performance CPR groupSituation in standard CPR groupSituation in high performance CPR groupPower, %Odds ratio0.0030.00311831.680.0320.03211761.600.0320.00311771.610.0030.00322841.680.0320.03222841.670.0320.00322771.600.0030.00323841.680.0030.00324841.680.0030.00325841.680.0320.03223841.670.0320.03224841.670.0320.03225851.670.0320.00323771.600.0320.00324771.600.0320.00325771.600.0030.00333841.680.0320.03233841.670.0320.00333771.600.0320.00333771.600.0030.00334841.680.0030.00335841.680.0320.03234841.670.0320.03235851.670.0320.00334771.600.0320.00335771.600.0030.00344841.680.0320.03244841.670.0320.00344771.600.0030.00345841.680.0320.03245851.670.0320.00345771.600.0030.00355841.680.0320.03255851.670.0320.00355771.60[^3]

[Table 3](#tbl3){ref-type="table"} shows the results of the simulation studies under conditions of varying the ICC and ratios of patient allocation between the two groups under situation 1 shown in [Table 1](#tbl1){ref-type="table"}. When the ICC was different in the two groups, the simulated power decreased by up to 10% from the target value of 80%. Overall, the difference between the target and simulated powers was approximately ±5%.Table 3Results of simulation studies under conditions of varying ICC and ratio of sample size between the two groups.Table 3ICC of standard CPR groupICC of high performance CPR groupSample size in standard CPR groupSample size in high performance CPR groupPower, %Odds ratio0.0030.00318001200821.680.0320.03218001200831.670.0320.00318001200751.600.0030.00312001800811.680.0320.03212001800831.680.0320.00312001800741.610.0030.00320001000801.680.0320.03220001000811.670.0320.00320001000731.600.0030.00310002000781.700.0320.03210002000791.690.0320.00310002000701.620.0030.00317501275831.680.0320.03217501275831.670.0320.00317501275761.600.0030.00312751750821.680.0320.03212751750841.680.0320.00312751750751.61[^4]

3.3. Type I error rate and power of design with sample size re-estimation {#sec3.3}
-------------------------------------------------------------------------

In this section, we describe the evaluation of the type I error rate under the null hypothesis (i.e., odds ratio = 1.0) and the power when the odds ratio was 1.60 (i.e., the true odds ratio is lower than the expected odds ratio of 1.65) when using the GEE method in the 10,000 simulated trials, with and without sample size re-estimation. The method of data generation was the same as that described in the previous section. The interim analysis was conducted when the sample size reached 1800 (60%) or 2400 (80%). For simplicity\'s sake, the cluster size was set to 25 for 60 EMS stations with equal patient allocation. The pre-specified, permitted maximum sample size (n~max~) that is often determined by budgetary limitations and feasibility of recruitment was 3500 or 4000.

[Table 4](#tbl4){ref-type="table"}, [Table 5](#tbl5){ref-type="table"} show the type I error rates and powers of trials performed with and without sample size re-estimation, along with the average sample size of trials with sample size re-estimation. As shown in [Table 4](#tbl4){ref-type="table"}, the type I error rate exceeded the nominal value of 5% by approximately 1% when the ICC between the two groups was different. Furthermore, the inflation was not corrected even if the trial included sample size re-estimation. We also found that the power did not sufficiently increase when using the sample size re-estimation based on the MP method ([Table 5](#tbl5){ref-type="table"}). This was likely because the probability that the interim results falls in a 'promising zone' was only approximately 15%. Furthermore, even if the sample size re-estimation was performed, increasing the sample size by 500 (or 1000) patients did not result in a satisfactory increase in the power.Table 4Type I error rates for the GEE method with and without sample size re-estimation.Table 4ICC of standard CPR groupICC of high performance CPR groupn~1~n~max~Type I error rate without SSR, %Type I error rate with SSR, %0.0030.003180035005.415.250.0320.032180035005.095.330.0320.003180035006.045.980.0030.003180040005.415.480.0320.032180040005.095.570.0320.003180040006.046.380.0030.003240035005.415.190.0320.032240035005.095.260.0320.003240035006.045.900.0030.003240040005.415.540.0320.032240040005.095.670.0320.003240040006.046.26[^5]Table 5Powers and average sample sizes for the GEE method with and without sample size re-estimation.Table 5ICC of standard CPR groupICC of high performance CPR groupn~1~n~max~Power without SSR, %Power with SSR, %Favorable, %Promising, %Unfavorable, %Average of final sample size after SSR0.0030.00318003500807958162730660.0320.03218003500737251163330660.0320.00318003500727251153330650.0320.03218004000808058152731010.0320.00318004000737350173331110.0030.00324003500727351163331080.0320.00324003500807964112530420.0030.00324004000737256123130470.0320.03224004000727256123130480.0320.0032400400080806511243068[^6]

4. Discussion {#sec4}
=============

The power decreased by 5--10% in some cases when the cluster size and patient allocation ratio observed in the actual trial were different from those expected in the sample size estimation. The power also decreased by 3--4% when the actual ICC was larger than that expected for sample size estimation. In addition, the use of the GEE method to evaluate the difference in the 1-month favorable neurological survival between two groups yielded inflation of the type I error rate by up to 1.0%. This tendency was also observed in other research studies \[[@bib13]\]. According to the results of the simulation studies conducted by Heo and Leon \[[@bib13]\], the GEE method resulted in the highest type I error rates when the ICC = 0. Finally, the increase in power produced by incorporating sample size re-estimation was limited.

5. Conclusions {#sec5}
==============

We determined the remarkable effects of sample size estimation and re-estimations in a cluster RCT for real-time feedback, debriefing, and retraining system of cardiopulmonary resuscitation for out-of-hospital cardiac arrests. We used of the GEE method for cluster RCT, and the inflation in type I error rate was adjusted. The misspecifications of the design parameters for sample size estimation possibly decreased the statistical power of testing by 5% on average in our simulation studies; however, the effect may vary depending on the situations that the investigators encounter. The precise estimation of design parameters for sample size estimation is generally challenging in cluster RCT for EMS system; therefore, it is important to conduct a trial simulation that assesses the statistical performance under a sample size based on the various expected values of the design parameters before beginning the trial.
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[^3]: ICC: intra-cluster correlation coefficient, CPR: cardiopulmonary resuscitation.

[^4]: ICC: intra-cluster correlation coefficient, CPR: cardiopulmonary resuscitation.

[^5]: GEE: generalized estimating equation, ICC: intra-cluster correlation coefficient, CPR: cardiopulmonary resuscitation, n~1~: sample size at interim analysis, n~max~: permitted maximum sample size, SSR: sample size re-estimation.
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